Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro

Journal of Ethnopharmacology

Volumn 126, Issue 2, 2009, Pages 345-349

  Zhang, Yi ^a,c   Li, Ping Ping ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bioluminescent measurements; Breast cancer; Dual luciferase reporter; Estrogenic activity; Hot flushes; Shu Gan Liang Xue Decoction

Indexed keywords

ANTINEOPLASTIC AGENT; BUPLEURUM CHINENSE EXTRACT; CHINESE DRUG; CURCUMA AROMATICA EXTRACT; CURCUMA EXTRACT; ESTRADIOL; ESTROGEN; HERBACEOUS AGENT; LITHOSPERMUM ERYTHRORHIZON EXTRACT; LITHOSPERMUM EXTRACT; LUCIFERASE; PAEONIA LACTIFLORA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PLANT EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SHU GAN LIANG XUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BUPLEURUM CHINENSE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CURCUMA AROMATICA; DRUG EFFECT; ESTROGEN ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LITHOSPERMUM ERYTHRORHIZON; MEDICINAL PLANT; PLASMID;

ANGIOSPERMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ESTROGENS; FEMALE; HUMANS; LUCIFERASES; LUMINESCENT PROTEINS; PHYTOTHERAPY; PLASMIDS; TRANSFECTION;

EID: 70350302635     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.08.016     Document Type: Article

References (25)

1. Cella D., and Fallowfield L.J. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Research and Treatment 107 (2008) 167-180
2. Chen J.C., Chang N.W., Chung J.G., and Chen K.C. Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells. The American Journal of Chinese Medicine 31 (2003) 363-377
3. Cherdshewasart W., and Sriwatcharakul S. Metabolic activation promotes estrogenic activity of the phytoestrogen-rich plant. Maturitas 59 (2008) 128-136
4. Deng W.P., Chao M.W., Lai W.F., Sun C., Chung C.Y., Wu C.C., Lin I.H., Hwang J.J., Wu C.H., Chiu W.T., Chen C.Y., and Redpath J.L. Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53. Cancer Letters 233 (2006) 315-327
5. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., and Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90 (1998) 1371-1388
6. Glaus A., Boehme C., Thurlimann B., Ruhstaller T., Hsu S.S., Morant R., Senn H.J., and Moos R.V. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Annals of Oncology 17 (2006) 801-806
7. Gutendorf B., and Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166 (2001) 79-89
8. Hung J.Y., Yang C.J., Tsai Y.M., Huang H.W., and Huang M.S. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clinical and Experimental Pharmacology & Physiology 35 (2008) 141-147
9. Li P.P. Effect of traditional Chinese medicine in improving hot flashes symptom of breast cancer. Chinese Journal of Integrative Medicine 10 (2004) 166-167
10. Li P.P., Wang W., and Xie Y.Q. In vivo effect of Shu-Gan-Liang-Xue decoction on estrogen. Chinese Journal of Oncology 25 (2003) 445-447
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1983) 55-63
12. Powles T., Eeles R., Ashley S., Easton D., Chang J., Dowsett M., Tidy A., Viggers J., and Davey J. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. The Lancet 352 (1998) 98-101
13. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. Journal of the American Medical Association 288 (2002) 321-333
14. Singh F., Gao D., Lebwohl M.G., and Wei H. Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells. Cancer Letters 200 (2003) 115-121
15. Stearns V., Ullmer L., Lopez J.F., Smith Y., Isaacs C., and Hayes D.F. Hot flushes. The Lancet 360 (2002) 1851-1861
16. Sun H., Xue D., Gao F., Ou-Yang T., and Li P.P. Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 29 (2009) 30-33
17. Sun Y., and Li P.P. The Shuganliangxue decoction's effects on the metabolism of tamoxifen. Chinese Journal of Experimental Traditional Medical Formulae 15 (2008) 76-80
18. Veronesi U., Maisonneuve P., Costa A., Sacchini V., Maltoni C., Robertson C., Rotmensz N., and Boyle P. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. The Lancet 352 (1998) 93-97
19. Wang W., Dai M., Zhu C., Zhang J., Lin L., Ding J., and Duan W. Synthesis and biological activity of novel shikonin analogues. Bioorganic & Medicinal Chemistry Letters 19 (2009) 735-737
20. Wu C.X., and Li P.P. Anti-tumor effect of Shu-Gan-Liang-Xue Decoction combined with tamoxifen on estrogen-dependent breast cancer. Chinese Journal of Experimental Traditional Medical Formulae 14 (2008) 31-34
21. Wu W. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene 22 (2003) 955-963
22. Zhang C., Zhang X., Zhang Y., Xu Q., Xiao H., and Liang X. Analysis of estrogenic compounds in Polygonum cuspidatum by bioassay and high performance liquid chromatography. Journal of Ethnopharmacology 105 (2006) 223-228
23. Zhang Y., Qian R.Q., and Li P.P. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells. Cancer Letters 284 (2009) 47-54
24. Zhang Y., and Zhang S.L. Inhibition effect of Guizhi-Fuling-decoction on the invasion of human cervical cancer. Journal of Ethnopharmacology 120 (2008) 25-35
25. Zong Z., Fujikawa-Yamamoto K., Tanino M., Teraoka K., Yamagishi H., and Odashima S. Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochemical and Biophysical Research Communications 219 (1996) 480-485